BGM Group (BGM) Competitors $7.82 +0.30 (+3.92%) Closing price 08/22/2025 03:57 PM EasternExtended Trading$7.94 +0.12 (+1.59%) As of 08/22/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BGM vs. KYMR, SRRK, AMRX, XENE, BHC, MOR, RARE, HCM, CRNX, and VKTXShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Kymera Therapeutics (KYMR), Scholar Rock (SRRK), Amneal Pharmaceuticals (AMRX), Xenon Pharmaceuticals (XENE), Bausch Health Cos (BHC), MorphoSys (MOR), Ultragenyx Pharmaceutical (RARE), HUTCHMED (HCM), Crinetics Pharmaceuticals (CRNX), and Viking Therapeutics (VKTX). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Kymera Therapeutics Scholar Rock Amneal Pharmaceuticals Xenon Pharmaceuticals Bausch Health Cos MorphoSys Ultragenyx Pharmaceutical HUTCHMED Crinetics Pharmaceuticals Viking Therapeutics BGM Group (NASDAQ:BGM) and Kymera Therapeutics (NASDAQ:KYMR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Which has more volatility and risk, BGM or KYMR? BGM Group has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Kymera Therapeutics has a beta of 2.18, meaning that its share price is 118% more volatile than the S&P 500. Is BGM or KYMR more profitable? BGM Group has a net margin of 0.00% compared to Kymera Therapeutics' net margin of -616.03%. BGM Group's return on equity of 0.00% beat Kymera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A Kymera Therapeutics -616.03%-31.60%-27.12% Does the media refer more to BGM or KYMR? In the previous week, Kymera Therapeutics had 2 more articles in the media than BGM Group. MarketBeat recorded 2 mentions for Kymera Therapeutics and 0 mentions for BGM Group. Kymera Therapeutics' average media sentiment score of 0.75 beat BGM Group's score of 0.00 indicating that Kymera Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment BGM Group Neutral Kymera Therapeutics Positive Which has preferable valuation and earnings, BGM or KYMR? BGM Group has higher earnings, but lower revenue than Kymera Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$25.10M30.27-$1.44MN/AN/AKymera Therapeutics$47.07M66.99-$223.86M-$3.47-12.71 Do analysts prefer BGM or KYMR? Kymera Therapeutics has a consensus target price of $59.11, indicating a potential upside of 34.04%. Given Kymera Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Kymera Therapeutics is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Kymera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 16 Buy rating(s) 3 Strong Buy rating(s) 3.10 SummaryKymera Therapeutics beats BGM Group on 9 of the 13 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$779.72M$3.11B$5.81B$9.76BDividend YieldN/A2.23%4.39%4.06%P/E RatioN/A21.0031.3626.05Price / Sales30.27209.44387.8788.42Price / CashN/A44.5038.0259.36Price / Book1.068.129.536.60Net Income-$1.44M-$54.72M$3.26B$265.65M7 Day Performance3.24%2.62%2.14%2.00%1 Month Performance-28.63%3.25%3.22%0.46%1 Year Performance33.36%10.82%30.18%18.88% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM GroupN/A$7.82+3.9%N/A+39.6%$779.72M$25.10M0.00298KYMRKymera Therapeutics2.722 of 5 stars$42.75-2.0%$59.11+38.3%-7.7%$3.07B$47.07M-12.36170SRRKScholar Rock4.5806 of 5 stars$30.75-2.5%$45.14+46.8%+282.8%$2.96B$33.19M-10.57140News CoverageAnalyst ForecastAMRXAmneal Pharmaceuticals3.3296 of 5 stars$9.30+0.4%$11.60+24.8%+14.4%$2.92B$2.85B930.438,100News CoveragePositive NewsInsider TradeXENEXenon Pharmaceuticals2.0478 of 5 stars$37.40-1.1%$53.20+42.3%-4.7%$2.88B$7.50M-10.53210News CoverageOptions VolumeBHCBausch Health Cos4.1797 of 5 stars$7.76-3.2%$9.00+15.9%+27.6%$2.87B$9.86B29.8620,700Analyst RevisionMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730Positive NewsRAREUltragenyx Pharmaceutical4.7276 of 5 stars$29.24-1.5%$81.50+178.7%-47.5%$2.82B$610.16M-5.291,294News CoverageHCMHUTCHMED2.6661 of 5 stars$16.17-1.6%$28.00+73.2%-6.7%$2.82B$602.20M0.001,811CRNXCrinetics Pharmaceuticals3.664 of 5 stars$29.67-0.2%$68.86+132.1%-41.8%$2.79B$1.04M-7.22210News CoveragePositive NewsInsider TradeVKTXViking Therapeutics3.9834 of 5 stars$24.66-41.4%$86.92+252.5%-59.8%$2.77BN/A-16.1220Trending NewsAnalyst ForecastOptions VolumeHigh Trading Volume Related Companies and Tools Related Companies KYMR Competitors SRRK Competitors AMRX Competitors XENE Competitors BHC Competitors MOR Competitors RARE Competitors HCM Competitors CRNX Competitors VKTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access